1. Home
  2. NMFC vs CDNA Comparison

NMFC vs CDNA Comparison

Compare NMFC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMFC
  • CDNA
  • Stock Information
  • Founded
  • NMFC 2010
  • CDNA 1998
  • Country
  • NMFC United States
  • CDNA United States
  • Employees
  • NMFC N/A
  • CDNA N/A
  • Industry
  • NMFC Finance/Investors Services
  • CDNA Medical Specialities
  • Sector
  • NMFC Finance
  • CDNA Health Care
  • Exchange
  • NMFC Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • NMFC 1.2B
  • CDNA 1.0B
  • IPO Year
  • NMFC 2011
  • CDNA 2014
  • Fundamental
  • Price
  • NMFC $10.39
  • CDNA $19.04
  • Analyst Decision
  • NMFC Hold
  • CDNA Buy
  • Analyst Count
  • NMFC 3
  • CDNA 6
  • Target Price
  • NMFC $11.00
  • CDNA $30.33
  • AVG Volume (30 Days)
  • NMFC 383.8K
  • CDNA 996.2K
  • Earning Date
  • NMFC 07-30-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • NMFC 12.63%
  • CDNA N/A
  • EPS Growth
  • NMFC N/A
  • CDNA N/A
  • EPS
  • NMFC 0.99
  • CDNA 1.07
  • Revenue
  • NMFC $366,773,000.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • NMFC N/A
  • CDNA $13.31
  • Revenue Next Year
  • NMFC N/A
  • CDNA $15.46
  • P/E Ratio
  • NMFC $10.48
  • CDNA $17.61
  • Revenue Growth
  • NMFC N/A
  • CDNA 25.92
  • 52 Week Low
  • NMFC $8.84
  • CDNA $13.48
  • 52 Week High
  • NMFC $12.55
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • NMFC 44.26
  • CDNA 55.64
  • Support Level
  • NMFC $10.74
  • CDNA $18.51
  • Resistance Level
  • NMFC $11.04
  • CDNA $19.62
  • Average True Range (ATR)
  • NMFC 0.17
  • CDNA 0.84
  • MACD
  • NMFC -0.07
  • CDNA 0.02
  • Stochastic Oscillator
  • NMFC 26.97
  • CDNA 66.12

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: